| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-09-07 21:26:16 UTC |
|---|
| Updated at | 2022-09-07 21:26:17 UTC |
|---|
| NP-MRD ID | NP0256561 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | 1-[(5as,7r,9as,11as)-7-hydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethanone |
|---|
| Description | Allopregnanolone belongs to the class of organic compounds known as gluco/mineralocorticoids, progestogins and derivatives. These are steroids with a structure based on a hydroxylated prostane moiety. 1-[(5as,7r,9as,11as)-7-hydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethanone is found in Homo sapiens. 1-[(5as,7r,9as,11as)-7-hydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethanone was first documented in 2022 (PMID: 35931327). Based on a literature review a significant number of articles have been published on Allopregnanolone (PMID: 36084357) (PMID: 36044784) (PMID: 36029538) (PMID: 35974667) (PMID: 35967446) (PMID: 35963123). |
|---|
| Structure | CC(=O)C1CCC2C3CC[C@H]4C[C@H](O)CC[C@]4(C)C3CC[C@]12C InChI=1S/C21H34O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h14-19,23H,4-12H2,1-3H3/t14-,15+,16?,17?,18?,19?,20-,21+/m0/s1 |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C21H34O2 |
|---|
| Average Mass | 318.5010 Da |
|---|
| Monoisotopic Mass | 318.25588 Da |
|---|
| IUPAC Name | 1-[(2S,5R,7S,15S)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]ethan-1-one |
|---|
| Traditional Name | 1-[(2S,5R,7S,15S)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]ethanone |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC(=O)C1CCC2C3CC[C@H]4C[C@H](O)CC[C@]4(C)C3CC[C@]12C |
|---|
| InChI Identifier | InChI=1S/C21H34O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h14-19,23H,4-12H2,1-3H3/t14-,15+,16?,17?,18?,19?,20-,21+/m0/s1 |
|---|
| InChI Key | AURFZBICLPNKBZ-SUZPBREPSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as gluco/mineralocorticoids, progestogins and derivatives. These are steroids with a structure based on a hydroxylated prostane moiety. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Steroids and steroid derivatives |
|---|
| Sub Class | Pregnane steroids |
|---|
| Direct Parent | Gluco/mineralocorticoids, progestogins and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Progestogin-skeleton
- 20-oxosteroid
- 3-alpha-hydroxysteroid
- Oxosteroid
- Hydroxysteroid
- 3-hydroxysteroid
- Cyclic alcohol
- Secondary alcohol
- Ketone
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Alcohol
- Aliphatic homopolycyclic compound
|
|---|
| Molecular Framework | Aliphatic homopolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Bukanova JV, Kondratenko RV, Solntseva EI: Positive allosteric modulators of GABA(A) receptor restore chloride current from blockade by competitive antagonists in a ligand-dependent manner. J Steroid Biochem Mol Biol. 2022 Aug 2;224:106158. doi: 10.1016/j.jsbmb.2022.106158. [PubMed:35931327 ]
- Potter NA, Arita Y, Peltier MR, Zelikoff JT: Ex vivo toxicity of E-cigarette constituents on human placental tissues. J Reprod Immunol. 2022 Dec;154:103737. doi: 10.1016/j.jri.2022.103737. Epub 2022 Aug 30. [PubMed:36084357 ]
- Kim JL, Kim SS, Hwang KS, Park HC, Cho SH, Bae MA, Kim KT: Chronic exposure to butyl-paraben causes photosensitivity disruption and memory impairment in adult zebrafish. Aquat Toxicol. 2022 Oct;251:106279. doi: 10.1016/j.aquatox.2022.106279. Epub 2022 Aug 24. [PubMed:36044784 ]
- Garcia-Baos A, Gallego-Landin I, Ferreres-Alvarez I, Puig-Reyne X, Castro-Zavala A, Valverde O, Martin-Sanchez A: Effects of fast-acting antidepressant drugs on a postpartum depression mice model. Biomed Pharmacother. 2022 Oct;154:113598. doi: 10.1016/j.biopha.2022.113598. Epub 2022 Aug 25. [PubMed:36029538 ]
- Ciccone N, Kovacheff MB, Frey BN: The pharmacotherapeutic management of premenstrual dysphoric disorder. Expert Opin Pharmacother. 2023 Jan;24(1):145-151. doi: 10.1080/14656566.2022.2114345. Epub 2022 Aug 22. [PubMed:35974667 ]
- Balan I, Aurelian L, Williams KS, Campbell B, Meeker RB, Morrow AL: Inhibition of human macrophage activation via pregnane neurosteroid interactions with toll-like receptors: Sex differences and structural requirements. Front Immunol. 2022 Jul 29;13:940095. doi: 10.3389/fimmu.2022.940095. eCollection 2022. [PubMed:35967446 ]
- Marciniak E, Mlotkowska P, Roszkowicz-Ostrowska K, Ciska E, Misztal T: Involvement of neurosteroids in the control of prolactin secretion in sheep under basal, stressful and pregnancy conditions. Theriogenology. 2022 Sep 15;190:73-80. doi: 10.1016/j.theriogenology.2022.08.013. Epub 2022 Aug 6. [PubMed:35963123 ]
- Hatipoglu E, Hacioglu Y, Polat Y, Arslan HF, Oner S, Ekmekci OB, Niyazoglu M: Do neurosteroids have impact on depression and cognitive functions in cases with acromegaly? Growth Horm IGF Res. 2022 Oct;66:101496. doi: 10.1016/j.ghir.2022.101496. Epub 2022 Jul 27. [PubMed:35952406 ]
- Cai H, Zeng C, Zhang X, Liu Y, Wu R, Guo W, Wang J, Wu H, Tang H, Ge X, Yu Y, Zhang S, Cao T, Li N, Liang X, Yang P, Zhang B: Diminished treatment response in relapsed versus first-episode schizophrenia as revealed by a panel of blood-based biomarkers: A combined cross-sectional and longitudinal study. Psychiatry Res. 2022 Oct;316:114762. doi: 10.1016/j.psychres.2022.114762. Epub 2022 Aug 3. [PubMed:35940088 ]
- Germann AL, Burbridge AB, Pierce SR, Akk G: Activation of the Rat alpha1beta2epsilon GABA(A) Receptor by Orthosteric and Allosteric Agonists. Biomolecules. 2022 Jun 21;12(7):868. doi: 10.3390/biom12070868. [PubMed:35883422 ]
- Mincheva G, Gimenez-Garzo C, Izquierdo-Altarejos P, Martinez-Garcia M, Doverskog M, Blackburn TP, Hallgren A, Backstrom T, Llansola M, Felipo V: Golexanolone, a GABA(A) receptor modulating steroid antagonist, restores motor coordination and cognitive function in hyperammonemic rats by dual effects on peripheral inflammation and neuroinflammation. CNS Neurosci Ther. 2022 Nov;28(11):1861-1874. doi: 10.1111/cns.13926. Epub 2022 Jul 26. [PubMed:35880480 ]
- Wald J, Henningsson A, Hanze E, Hoffmann E, Li H, Colquhoun H, Deligiannidis KM: Allopregnanolone Concentrations in Breast Milk and Plasma from Healthy Volunteers Receiving Brexanolone Injection, With Population Pharmacokinetic Modeling of Potential Relative Infant Dose. Clin Pharmacokinet. 2022 Sep;61(9):1307-1319. doi: 10.1007/s40262-022-01155-w. Epub 2022 Jul 23. [PubMed:35869362 ]
- Qrareya AN, Mahdi F, Kaufman MJ, Ashpole NM, Paris JJ: Age-related neuroendocrine, cognitive, and behavioral co-morbidities are promoted by HIV-1 Tat expression in male mice. Aging (Albany NY). 2022 Jul 12;14(13):5345-5365. doi: 10.18632/aging.204166. Epub 2022 Jul 12. [PubMed:35830469 ]
- Moncayo JA, Ayala IN, Argudo JM, Aguirre AS, Parwani J, Pachano A, Ojeda D, Cordova S, Mora MG, Tapia CM, Ortiz JF: Understanding Protein Protocadherin-19 (PCDH19) Syndrome: A Literature Review of the Pathophysiology. Cureus. 2022 Jun 10;14(6):e25808. doi: 10.7759/cureus.25808. eCollection 2022 Jun. [PubMed:35822151 ]
- Boi L, Petralla S, Monti B, Talani G, Sanna E, Pisu MG, Calderisi G, Maciocco E, Serra M, Concas A, Porcu P: Chronic treatment with hormonal contraceptives alters hippocampal BDNF and histone H3 post-translational modifications but not learning and memory in female rats. Horm Behav. 2022 Aug;144:105218. doi: 10.1016/j.yhbeh.2022.105218. Epub 2022 Jul 1. [PubMed:35785712 ]
- Gilfarb RA, Leuner B: GABA System Modifications During Periods of Hormonal Flux Across the Female Lifespan. Front Behav Neurosci. 2022 Jun 16;16:802530. doi: 10.3389/fnbeh.2022.802530. eCollection 2022. [PubMed:35783228 ]
- Vasiliu O: Investigational Drugs for the Treatment of Depression (Part 1): Monoaminergic, Orexinergic, GABA-Ergic, and Anti-Inflammatory Agents. Front Pharmacol. 2022 Jun 14;13:884143. doi: 10.3389/fphar.2022.884143. eCollection 2022. [PubMed:35774601 ]
- Bassani TB, Bartolomeo CS, Oliveira RB, Ureshino RP: Progestogen-Mediated Neuroprotection in Central Nervous System Disorders. Neuroendocrinology. 2023;113(1):14-35. doi: 10.1159/000525677. Epub 2022 Jun 27. [PubMed:35760047 ]
- LOTUS database [Link]
|
|---|